<DOC>
	<DOCNO>NCT01909713</DOCNO>
	<brief_summary>The purpose study determine tolerability Cetaphil® DermaControl™ Foam Wash Moisturizer SPF 30 pediatric subject ( 7-11 ) acne prone skin .</brief_summary>
	<brief_title>Tolerability Foaming Facial Cleanser Moisturizer SPF 30 Pediatric Population ( 7-11 ) With Acne Prone Skin .</brief_title>
	<detailed_description>This open-label , single center study conduct United States evaluate tolerability Cetaphil® DermaControl™ skin care product use least daily 22 day male female subject age 7 11 acne prone skin . There 4 visit course study : screening ( within 7 day visit 1 ) , visit 1 ( baseline /day1 ) , visit 2 ( day 8 ) , visit 3 ( day 22/exit ) . Tolerability assessment perform board certify dermatologist visit . Subjects complete baseline skin care regimen questionnaire visit 1 . Hydration assessment compete visit 1 , 2 , 3 . A subject satisfaction questionnaire complete visit 3 . Adverse event assessment conduct subject every clinic visit inform consent/assent sign .</detailed_description>
	<criteria>Male female subject 711 year age Subjects acneprone skin [ Global severity acne ( GSA ) Score 1 ( almost clear ) 2 ( mild ) oiliness evaluation score GSA Score 0 ( none ) oiliness evaluation score great equal 1 ( mild ) ] Subjects visible skin condition facial hair could interfere evaluation Subjects take medication , supplement , nonprescription treatment , opinion principal investigator/board certified dermatologist , could interfere test result include regimen steroidal/non steroidal antiinflammatory drug antihistamine Subjects currently treatment asthma diabetes ( insulindependent ) Subjects abnormal pigment vascular skin lesion , abnormal skin pigmentation , body art ( tattoo , permanent temporary ) face , could interfere subsequent evaluation dermal responsiveness</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>acne , pediatric</keyword>
</DOC>